COVID-19 Investigations Webinar – Current Congressional, Federal Agency, and State AG Oversight & Investigations Priorities
Webinar | 07.15.20, 8:00 AM EDT - 9:00 AM EDT
Join Crowell & Moring’s enforcement and investigations partners for a comprehensive overview of Congressional, Federal and State attorneys general COVID-19 enforcement actions. Learn about the prosecutions, Congressional document requests, formal investigations, and State actions underway. What industries, organizations, and companies have been targeted to date? How does the current enforcement focus impact future investigations?
Our partners will provide an overview of matters that are currently of particular focus and offer their insights on what industry can expect in the coming months leading up to the 2020 elections. The panel will focus on oversight and investigations before:
- Congress
- Food and Drug Administration
- Department of Health and Human Services
- Department of Justice
- State Attorneys General
The panel will include members of our Government Affairs, Health Care, White Collar, and State Attorneys General practice groups. The panelists include:
- Jim Flood, a former federal prosecutor and counsel to Senator Charles E. Schumer (D-NY)
- John Fuson, a former associate chief counsel at the Food and Drug Administration
- Natalie O. Ludaway, former Chief Deputy of the Office of Attorney General (OAG) for the District of Columbia
- Rebecca Monck Ricigliano, a former Assistant United States Attorney in the Southern District of New York and First Assistant Attorney General for New Jersey
For more information, please visit these areas: Government Affairs, White Collar and Regulatory Enforcement
Contact
Insights
Webinar | 12.10.25
In 2025, the U.S. Government’s policy statements and Executive Orders have had far-reaching impacts for government contractors and grant recipients. Although terminations, stop work orders, and de-scopes have affected private companies, non-profits, and universities doing business across multiple agencies, the U.S. Government’s policies relating to the U.S. Agency for International Development (USAID) has caused particular confusion and uncertainty relating to performance, compliance, and contractual procedure. Key questions have included the potential impacts of official and less formal communications from the U.S. Government, procedural issues arising from the move of certain functions to the U.S. Department of State, and the effect of various pending litigations. As businesses and organizations plan for 2026, the importance of preserving their rights and maximizing potential recovery opportunities remains paramount.
Webinar | 11.24.25
AI in the Workplace: EU Rules for When Humans and Bots Team Up
